Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1996
03/21/1996WO1996008261A1 Probiotic compositions
03/21/1996WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
03/21/1996WO1996008252A1 Codeine containing formulations
03/21/1996WO1996008251A1 Scopolamine plaster
03/21/1996WO1996008245A1 Patch for external use
03/21/1996WO1996008243A1 Pharmaceutical preparation containing metformin and a process for producing it
03/21/1996WO1996008238A1 Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
03/21/1996WO1996008234A1 Container with multi-phase composition for use in diagnostic and therapeutic applications
03/21/1996DE4433101A1 Wasserlösliche Dextranfettsäureester und ihre Verwendung als Solubilisatoren Water-soluble dextran fatty and their use as solubilizers
03/21/1996DE4432757A1 Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung Pharmaceutical composition comprising metformin and methods of their production
03/21/1996CA2199721A1 Pharmaceutical compositions containing d2o
03/21/1996CA2198361A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996CA2158724A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
03/20/1996EP0701816A2 Percutaneous absorption preparation containing isosolide dinitrate
03/20/1996EP0701815A1 Process for producing powders, granulates or pellets containing active substances and a structure consisting of hydrophilic macromolecules, and use thereof
03/20/1996EP0701449A1 Process for the preparation of an oral solid dosage form containing diclofenac
03/20/1996EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers
03/20/1996EP0701436A1 Process
03/20/1996EP0701434A1 Preparations containing silicon dioxide to improve the taste thereof
03/20/1996EP0648102B1 Cosmetic composition in the form of a gelled silicone/water triple water/oil emulsion
03/20/1996EP0605497B1 Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln)
03/20/1996EP0583459B1 Cosmetic or dermatological composition in the form of an oil-in-water dispersion capable of forming composite films
03/20/1996EP0540670B1 Method for preparation of crosslinked polyamines
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/20/1996EP0355140B1 Human monoclonal anti-hiv-i-antibodies
03/20/1996CN1118992A Cosmetic compositions
03/20/1996CN1118989A Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
03/19/1996US5500416 Percutaneous absorption promoting agent and dermatologic preparation containing the same
03/19/1996US5500362 Chimeric antibody with specificity to human B cell surface antigen
03/19/1996US5500232 Acid, calcium source
03/19/1996US5500226 Pharmaceutical composition having analgesic activity
03/19/1996US5500224 Pharmaceutical compositions containing nanocapsules
03/19/1996US5500222 Mixed with monoglyceride permeation enhancer
03/15/1996CA2157754A1 Percutaneous absorption preparation
03/14/1996WO1996007738A2 Modified human c3 proteins
03/14/1996WO1996007670A1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
03/14/1996WO1996007440A2 Methods and apparatus for the delivery of solid drug compositions
03/14/1996WO1996007432A1 Transfer of molecules into the cytosol of cells
03/14/1996WO1996007429A1 Liquid immunoglobulin formulations
03/14/1996WO1996007427A1 Capsular polysaccharide immunomodulator
03/14/1996WO1996007414A1 Ointment
03/14/1996WO1996007398A2 Sustained release of peptides from pharmaceutical compositions
03/14/1996WO1996007397A2 Delivery of solid drug compositions
03/14/1996WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
03/14/1996CA2197888A1 Modified human c3 proteins
03/13/1996EP0700997A1 Production in bacteria and yeast of hemoglobin and analogues thereof
03/13/1996EP0700680A1 Gepirone dosage form
03/13/1996EP0700679A1 Injectable liposomal compositions
03/13/1996EP0700678A1 Stable lipid emulsion
03/13/1996EP0700444A1 Immunotoxins comprising gelonin and an antibody
03/13/1996EP0700376A1 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
03/13/1996EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
03/13/1996EP0700295A1 Vitamin b 12? mediated oral delivery systems for gcsf and epo
03/13/1996EP0700294A1 Intramuscular and subcutaneous injection solution for animals
03/13/1996EP0700290A1 Rectal compositions
03/13/1996EP0700285A1 A drug delivery composition for alpha-adreno receptor blocking agents
03/13/1996EP0700284A1 Controlled release oxybutynin formulations
03/13/1996EP0700283A1 Liquid antacid compositions
03/13/1996EP0665746A4 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF-g(a)PE 40?ab.
03/13/1996EP0591331B1 Method of preparing nanoparticles
03/13/1996EP0540613B1 Products and processes for the treatment of the alimentary canal
03/13/1996EP0502962B1 Hirudinmuteins and their polyalkylene glycol conjugates
03/13/1996EP0491007B1 Structural alterations of the egf receptor gene in human gliomas
03/13/1996EP0438497B1 Vasopermeability-enhancing conjugates
03/13/1996EP0401384B1 Chemically modified granulocyte colony stimulating factor
03/13/1996CN1118576A Powdery pharmaceutical preparation and method of manufacturing same
03/13/1996CN1118575A Optical isomerization inhibitor
03/13/1996CN1118571A Bisacodyl dosage form
03/13/1996CN1118254A Pharmaceutical compositions having good dissolution properties
03/13/1996CN1118252A Stabized solutions of platinum (II) antitumor agents
03/13/1996CA2157849A1 Injectable liposomal pharmaceutical preparations
03/12/1996US5498788 Inclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof
03/12/1996US5498729 Prodrug compositions
03/12/1996US5498436 Coprocessed galactomannan-glucomannan
03/12/1996US5498422 Sustained release capsule
03/12/1996US5498421 Composition useful for in vivo delivery of biologics and methods employing same
03/12/1996CA2053317C Active carbonates of polyalkylene oxides for modification of polypeptides
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006641A1 Conjugates of vascular endothelial growth factor with targeted agents
03/07/1996WO1996006638A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996WO1996006636A1 Topical anti-inflammatory composition and method
03/07/1996WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996WO1996006632A1 Compositions and methods for delivery of polypeptides
03/07/1996WO1996006623A1 Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications
03/07/1996WO1996006622A1 Hyaluronic acid and derivatives for modulation of cellular activity
03/07/1996WO1996006618A1 Cosolvent parenteral formulation of tirilazad
03/07/1996WO1996006617A1 Liposome preparation
03/07/1996WO1996006615A1 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
03/07/1996WO1996006613A1 Topical ketoconazole emulsions
03/07/1996WO1996006598A1 Aerosol drug formulations containing polyglycolyzed glycerides
03/07/1996WO1996006597A1 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
03/07/1996WO1996006528A1 Ionene polymers containing biologically-active anions
03/07/1996WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy
03/07/1996WO1996000087A3 Kit for pretargeting and novel pretargeting conjugates
03/07/1996DE4431251A1 Skin cream, and base cream for cosmetics, eczema etc.
03/07/1996CA2199005A1 Compositions and methods for delivery of polypeptides
03/07/1996CA2198722A1 Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications
03/07/1996CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
1 ... 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 ... 1712